Abstract

The present invention relates to novel solid-state forms of Rovadicitinib, specifically amorphous forms, processes for their preparation, pharmaceutical compositions comprising them, and their use in therapy.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS